The objective of the current study was to improve colorectal cancer (CRC) screening uptake with the fecal immunochemical test (FIT). The current study investigated the differential impact of a multicomponent, targeted, low-literacy educational intervention compared with a standard, nontargeted educational intervention. METHODS: Patients aged 50 to 75 years who were of average CRC risk and not up-to-date with CRC screening were recruited from either a federally qualified health center or a primary care community health clinic. Patients were randomized to the intervention condition (targeted photonovella booklet/DVD plus FIT kit) or comparison condition (standard Centers for Disease Control and Prevention brochure plus FIT kit). The main outcome was screening with FIT within 180 days of delivery of the intervention. RESULTS: Of the 416 participants, 54% were female; the participants were racially and ethnically diverse (66% white, 10% Hispanic, and 28% African American), predominantly of low income, and insured (the majority had county health insurance). Overall, the FIT completion rate was 81%, with 78.1% of participants in the intervention versus 83.5% of those in the comparison condition completing FIT (P 5 .17). In multivariate analysis, having health insurance was found to be the primary factor predicting a lack of FIT screening (adjusted odds ratio, 2.10; 95% confidence interval, 1.04-4.26 [P 5 .04]). CONCLUSIONS: The multicomponent, targeted, low-literacy materials were not found to be significantly different or more effective in increasing FIT uptake compared with the nontargeted materials. Provision of a FIT test plus education may provide a key impetus to improve the completion of CRC screening. The type of educational material (targeted vs nontargeted) may matter less. The findings of the current study provide a unique opportunity for clinics to adopt FIT and to choose the type of patient education materials based on clinic, provider, and patient preferences. Cancer 2017;123:1390-400. V C 2016 American Cancer Society.
INTRODUCTION
Colorectal cancer (CRC) is the second leading cause of cancer death among men and women in the United States, 1 yet approximately 40% of adults aged 50 to 75 years remain unscreened. 2, 3 Racial and ethnic minorities, recent immigrants, individuals of low socioeconomic status, individuals with limited health literacy, patients without health insurance, and patients who lack a regular source of health care are at greatest risk of not being screened. 1, [4] [5] [6] Impediments to CRC screening among racial/ethnic minority and underserved patients include a myriad of factors. Providers may have limited time for discussions regarding CRC screening or low awareness of contemporary national guidelines regarding which test to recommend. [7] [8] [9] [10] Some providers may believe that colonoscopy is superior to other CRC screening tests and thus is the only optimal screening and prevention test. 9, 10 Conversely, patients may experience scheduling issues, 11 transportation concerns, 10 and worry concerning cost. 8, 10, 11 Patients also may lack awareness and knowledge regarding the importance of regular CRC screening, which contributes to suboptimal screening. 8, 10, 12 Furthermore, cognitions and emotions such as lack of perceived benefits, 8, 13 fear, 10, 11, 13, 14 and embarrassment 14 may add to low screening rates. Finally, logistical, systemic, and structural impediments such as low clinic attention to CRC screening promotion, underdeveloped clinic tracking systems, and an inability to offer follow-up colonoscopy and care for those with a positive stool blood test may get in the way of CRC screening programs. 9, 15, 16 Federally qualified health centers (FQHCs) and other community health clinics (CHCs) provide comprehensive primary health care for underserved patients. 17 Recently, high-sensitivity and high-specificity fecal occult blood tests (FOBT) and fecal immunochemical tests (FIT) have emerged as a preferred initial screening modality within clinics due to convenience, ease of use, and low cost compared with colonoscopy. 16, 18, 19 FOBT/FIT may help to reduce CRC screening disparities and overcome several previously mentioned factors that often account for suboptimal CRC screening rates.
Recent studies aimed at improving CRC screening rates have used a variety of patient-directed interventions (eg, written materials, DVDs, mailed FOBTs and reminders, telephone counseling/patient navigation, and outreach invitations for FIT and colonoscopy screening) that have resulted in increases in screening rates ranging from 13% to 59%. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] However, to achieve national screening goals, interventions that boost uptake above these rates are needed. To the best of our knowledge, approaches to increase and maintain long-term CRC screening with FIT in medically underserved populations have not been established to date. Interventions emphasizing colonoscopy may ignore patient screening preferences and do not take into account the infrastructure necessary to deliver colonoscopy. 29 Innovative, evidence-based strategies that incorporate a patient's CRC screening preferences and consider the resources and strengths of FQHCs and CHCs are needed to achieve or exceed national CRC screening goals.
Existing CRC screening interventions often include an educational component designed to increase CRC screening. However, these interventions are geared toward individuals with high literacy levels, do not reflect the local community, and lack specific actionable messages. 29, 30 A novel, yet practical, approach to increasing CRC screening is to provide in-clinic FIT access, along with targeted educational materials that are informed by the local community to activate patient awareness and patient engagement, and to promote patient-physician communication regarding CRC screening.
The purpose of the Colorectal Cancer Awareness, Research, Education and Screening (CARES) trial was to test the differential impact of a multicomponent, targeted, low-literacy intervention (photonovella booklet and DVD plus FIT kit) (hereafter denoted as CARES condition) compared with a standard Centers for Disease Control and Prevention (CDC) "Screen for Life" brochure plus FIT kit (hereafter denoted as comparison condition) to increase CRC screening. The intervention addressed the following research questions: 1) does the CARES condition produce greater FIT uptake compared with the comparison condition; and 2) what are the sociodemographic and health-related beliefs associated with completion versus noncompletion of FIT.
MATERIALS AND METHODS

Trial Design
The CARES study was an intervention trial designed to increase CRC screening; the trial is registered at ClinicalTrials.gov. This study was conceptualized, designed, and implemented within a larger, ongoing community-based participatory research initiative, the Tampa Bay Community Cancer Network (TBCCN). The TBCCN is a partnership between 28 community organizations and a National Cancer Institute-designated comprehensive cancer center formed to address health disparities in the Tampa Bay region. [31] [32] [33] The CARES condition featured a targeted, lowliteracy, photonovella booklet and DVD informed by the constructs of the Preventive Health Model (PHM) (eg, salience, self-efficacy). 21, [34] [35] [36] The photonovella/DVD included storylines depicting local characters that modeled the test-specific behavior of screening with the FIT kit. 9, [37] [38] [39] The photonovella/DVD content, storyline, photos, and graphics were informed by our prior work. 9, 31, 39, 40 The comparison condition featured a standard trifold CRC screening brochure developed by the CDC. Enrolled participants received a FIT kit; written and verbal FIT kit instructions; a self-addressed, stamped envelope in which to mail the FIT kit for processing; and an in-person FIT kit collection demonstration.
Study Participants
Eligible participants were those: 1) receiving care at either a FQHC or CHC; 2) aged 50 to 75 years; 3) currently not up-to-date as per CRC screening guidelines (never screened or previously screened but now overdue); 4) at average risk of CRC (ie, no symptoms of CRC, personal diagnosis of CRC, or bowel diseases); and 5) able to speak and read English. Eligible individuals provided written informed consent before baseline data collection and randomization. The Institutional Review Boards of the University of South Florida and the Florida Department of Health approved the current study.
Procedure
The trial was conducted between July 2012 and August 2014 at an FQHC and CHC (2 sites) associated with the TBCCN. CRC screening rates for the 12 months before the CARES trial in the partnering CHC and FQHC clinics were 18% and 35%, respectively, based on Uniform Data Standards using a 3-card FOBT. Two Master's-level prepared, racially and ethnically diverse research study coordinators approached potential participants in the clinic waiting area to introduce the study and assess eligibility. For those who were eligible, the coordinator explained the trial, answered questions, and obtained informed consent. Before delivery of the intervention, baseline interviews were conducted in-person by trained coordinators. Participants were compensated $10 for completing the baseline interview. Participants were randomly assigned (1:1) to receive either the CARES (targeted photonovella booklet/DVD plus FIT kit) or comparison condition (standard CDC brochure plus FIT kit). In a private setting, participants in both conditions received written and verbal FIT kit collection instructions, along with an in-person FIT kit collection demonstration. The research study coordinators provided a brief demonstration that entailed showing participants the components of the kit and how to collect and mail a sample. In both conditions, intervention materials were delivered before the patient's medical encounter. Participants in the CARES condition viewed the DVD in the clinic and received a copy to take home.
Measures
Screening uptake
Screening uptake was measured by return of a completed FIT kit to the study coordinating office at the cancer center. The kit return packets were prestamped and selfaddressed to be returned only to the cancer center. This provided an objective verification of screening completion. The primary outcome was return of a completed FIT kit within 180 days of intervention delivery. The secondary outcome was time to FIT kit return, based on the date the kit was provided and the date the completed kit was received by the study team.
PHM health belief variables
PHM constructs were assessed with 7 validated, multiitem PHM subscales on a 5-point response scale ranging from 1 (strongly disagree) to 5 (strongly agree). 21, [34] [35] [36] Perceived susceptibility assessed the perceived likelihood of developing CRC or polyps. Response efficacy assessed beliefs regarding whether CRC can be detected early through screening and whether removal of CRC polyps can prevent CRC. Salience and coherence assessed whether CRC screening made sense and would help to protect the participant's health. Cancer worry assessed worry regarding having positive results. Social influence assessed perceived social support for CRC screening from important others (eg, family/friends and health care provider) and desire to comply with recommendations for CRC screening. Self-efficacy assessed confidence in the participant's ability to complete a FIT kit. Religious beliefs assessed the extent to which religious beliefs influenced health behaviors.
Health literacy
The Rapid Estimate of Adult Literacy in Medicine-Revised was used to assess health literacy. 41 One point was given for each item pronounced correctly; of a maximum score of 8, a score of 6 was considered at risk of low health literacy.
Awareness
A total of 3 yes-no items assessed whether participants had previously heard of FOBT/FIT, sigmoidoscopy, and/or colonoscopy. 42 Nine additional items further assessed CRC screening knowledge. One point was given for each correct response and a total awareness score was calculated by summing the points earned for all items.
Trust in health care system
The 10 items from the Health Care System Distrust Scale 43 assessed the extent to which an individual trusts hospitals, health insurance companies, medical research, and the broader health care system. Participants responded with a 5-point scale ranging from 1 (strongly disagree) to 5 (strongly agree), with 3 items reverse-coded. Higher scores indicated greater distrust.
Sociodemographic variables
Participants responded to items regarding their age, sex, race, ethnicity (ie, Hispanic vs non-Hispanic), income, education, employment status, marital status, recruitment
Original Article site (FQHC or CHC), and health insurance status. Health insurance included county health insurance coverage, a publicly funded insurance plan for individuals who reported very low incomes. The plan covers basic primary health services at county public health department and contracted community clinics. The plan requires preapproval by plan administrators after physician recommendation of colonoscopy.
Statistical Analyses
Statistical analyses were conducted using SAS statistical software. 44 Student t tests and chi-square analyses were conducted to examine group differences for sociodemographic and health-related variables. The study was statistically powered to detect a 10-percentage point difference between conditions with 80% power. Variables with a group difference P value < .10 were considered potential confounding variables in primary analyses. Subgroup analyses were performed using logistic regression with a model including intervention, sociodemographic, or psychosocial variables of interest, and their interaction. Significant interactions were investigated using simple effects analyses. Finally, predictors of failure to return the FIT kit (across intervention groups) were assessed using univariate logistic regression. Predictors found to be significant in univariate analyses were further assessed using multivariable logistic regression. A 2-sided P value of < .05 was considered to be statistically significant.
RESULTS
Participant Characteristics
A total of 1213 patients were evaluated and 497 patients were identified as eligible (Fig. 1) . The primary reason for ineligibility was self-report of being up-to-date for CRC screening (517 of 1231 individuals evaluated [43%]). The number of eligible patients enrolled and analyzed was 416, with 210 patients randomized to the CARES condition and 206 patients randomized to the comparison condition. Participant characteristics are shown in Tables 1  and 2 . The average age of the participants was 55 years (standard deviation, 4.11 years). The sample was 54% female, and 24% were employed, 66% were white, 28% were black, 24% had less than a high school education, 63% reported a household income of <$10,000, and 61% had health insurance (primarily county health insurance). Rates of prior CRC screening were low: 31% of participants had prior screening (with any test). Among participants with prior CRC screening, the majority reported prior screening with FOBT. There were no intervention group differences noted with regard to prior screening (Table 1) and FOBT (27.2% and 28.6%, respectively, in the CARES condition and comparison condition). Four variables assessed at baseline exhibited group differences at a P<.10 and were controlled in subsequent analyses (employment status, PHM religious beliefs, PHM self-efficacy, and trust in health care).
Screening and Time to FIT Uptake
FIT kit uptake for the entire sample was 80.8%, and there were no significant group differences noted by study condition. Screening uptake was 78.1% in the CARES condition and 83.5% in the comparison condition (P 5 .17). With regard to time to FIT kit uptake, no difference was observed between the conditions (P 5 .32). FIT uptake mostly occurred within 30 days, and virtually no kits were returned after 90 days. The influence of condition on FIT kit uptake was assessed in a model including the 4 potential confounds. Intervention condition was not found to be a significant predictor of FIT kit uptake (odds ratio [OR], 0.70; 95% confidence interval [95% CI], 0.42-1.16 [P 5 .17] ). None of the potential confounds were found to be significant predictors of uptake (all P > .26).
Medical chart reviews were conducted only for those participants who did not return the FIT kit to determine whether CRC screening (FOBT/FIT or endoscopy) was obtained through other sources. Of the 80 participants who did not return a FIT kit, 5 participants completed screening. All those participants completed an FOBT. These additional screenings did not affect the overall study findings.
Subgroup Analyses
A significant interaction was observed for racial/ethnic minority status, family history of cancer, annual physical examination, and cancer awareness score (Table 3 ). In the CARES condition, FIT uptake was lower for minorities, those with a family history of cancer, those having an annual physical examination, and those with higher cancer awareness scores.
Factors Associated With Failure to Complete FIT Screening
In univariate analysis, within the entire sample, there were several factors found to be significantly associated with failure to return the FIT kit: having health insurance (OR, 2.14; 95% CI, 1. 
Clinical Findings
Of the 336 participants who completed FIT kits, 21 kits produced abnormal results (6.3%). Sixteen participants completed colonoscopies, and 5 participants refused to complete colonoscopies. Of participants with verified colonoscopy results, 1 was diagnosed with rectal cancer, 10 had polyps (range, 1-20 polyps), and the remainder had no polyps.
DISCUSSION
The current study sought to assess whether the multicomponent, targeted, low-literacy CARES condition produced greater FIT uptake compared with the nontargeted condition. However, the results indicate that the targeted intervention materials within the CARES condition did not have a greater effect on FIT uptake compared with the nontargeted standard materials within the comparison condition. These results are similar to those of prior studies, which did not find a significant difference in rates of CRC screening between conditions after a patient-level intervention.
45-51
The results of the current study demonstrated an overall FIT screening rate of 80.8%, which exceeds the Healthy People 2020 goal of 70.5% 52 and meets the CDC goal to reach 80.0% by 2018. 53 The high FIT uptake was nearly double the up-to-date rate of 43% reported among those evaluated for eligibility within our clinic settings (Fig. 1 ). Because the current study did not include a usual-care condition, this up-to-date rate of 43%, albeit not objectively verified, provides a contemporary (during the course the trial) measure for benchmarking screening under usual care. In addition, FIT uptake in the current trial was higher than reported screening rates in other studies in similar low-income and community clinic populations. 19, 21, [46] [47] [48] [54] [55] [56] [57] The high CRC screening in the current study may be related to: 1) provision of FIT kits, accompanied by written and verbal instructions, and collection demonstration in both conditions; 2) ease of use of the single-application FIT kits versus the traditional 3-card FOBT that had been used in these clinics before and at the time of study enrollment; and 3) assurances to patients in both conditions that they would be linked to colonoscopy after an abnormal FIT, thus alleviating any cost concerns among uninsured individuals. As such, addressing practical barriers (eg, facilitating access to FIT kits with demonstration of sample collection) and offering education in the clinic may increase CRC screening rates, which are simple yet important steps toward reducing health disparities. The results of the current study found higher uptake rates than other prior studies that provided access to screening (eg, FOBT/FIT or colonoscopy); it is possible that the human interactions with study coordinators in clinics also fostered trust and improved FIT kit use. Many prior studies that have compared an intervention with usual care have demonstrated statistically significant intervention effects in CRC screening. 7, 19, 22, [25] [26] [27] 58, 59 During the conception of the CARES study with our community partners, an integral design feature was to ensure equal access to CRC screening among all participants. Thus, the current trial did not contain a traditional usual-care condition and instead provided CRC screening with a FIT kit to all participants to compare targeted versus nontargeted educational materials. It was believed that FIT uptake would likely increase among all participants, and the CARES condition would produce higher screening rates than the comparison condition due to the added attention placed on targeting and visual elements (ie, photonovella/DVD) during the intervention developmental phase. However, FIT screening and time to FIT kit return in the CARES condition was not found to be statistically significantly different from the comparison condition. The current study findings suggest that the targeted intervention comprised of photonovella and a DVD was not more effective than the standard brochure in promoting FIT uptake.
The comparable outcomes between the 2 intervention conditions may be because individuals in both groups received education and access to FIT. 49 Intervention materials in both conditions worked well and the type of education (targeted vs nontargeted) appeared to matter less. These findings are consistent with other studies that have included educational materials and a screening test as part of the intervention. 21, 22, 49 It also is possible that patients did not need additional materials beyond the simple distribution of the kit and instructions regarding how to complete it. For example, in another clinic-based trial that distributed FOBT kits, screening rates did not differ across intervention groups but were higher than the usualcare group. 21 This finding also may suggest the value of readily available materials (nontargeted brochure) versus more elegant, expensive ones (targeted photonovella/ DVD) when paired with access to FIT screening and follow-up care, if needed.
A significant predictor of FIT kit return was health insurance. Individuals without health insurance were more likely to return their FIT kits than those with health insurance. This suggests that delivering free FIT kits effectively reaches uninsured patients, for whom cost is often an impediment. Participants in the current study also were aware that they would be navigated to colonoscopy if the FIT tested positive. It is possible that individuals with health insurance may have preferred to undergo colonoscopy screening instead. To assess this potential explanation, chart review at 12 months after the intervention was conducted for all patients who did not return the study-provided FIT. Only 5 of 80 patients had verified evidence of any CRC screening during the study period (all 5 were FOBT). Thus, our straightforward intervention has the ability to directly contribute to health equity in low-resource clinics with limited access to colonoscopy screening. In interaction analyses, FIT uptake was found to be lower in the CARES condition for the following subgroups: racial/ethnic minorities, those with a family history of cancer, those having an annual physical examination, and those with higher cancer awareness scores. The specific reason for lower FIT uptake in these subgroups is unclear. It is plausible that some participants preferred a different screening modality other than FIT due to their family history of cancer and health care experiences. At this time, we do not have data to substantiate this assertion; individuals screened outside of the current trial during the study period completed FOBT. Further follow-up of the patients in these 4 subgroups is required to assess future long-term screening behaviors.
The clinics preferred our trial design because it took into account what was known about CRC disparities and the effectiveness of CRC education and access to testing. The results of the current study demonstrated that FIT uptake across conditions were comparable. This finding has important patient education implications for resource-limited environments, such as community clinics. The findings of the current study suggest that clinics can choose the type of patient education materials based on clinic, provider, and patient preferences. For example, clinics might use CDC educational materials for general populations and reserve targeted materials for a subset of patients who require in-depth education and could benefit from detailed step-by-step written and illustrative video instructions regarding FIT stool collection.
Aspects of the trial setting also are important to discuss. First, before the trial, the clinics in this study minimally used screening with colonoscopy and instead were oriented toward the use of stool blood tests that included the traditional, low-cost, yet more cumbersome 3-card guaiac FOBT. Indeed, before the onset of the study, clinics had not been aware of the newer modality of FIT screening. The introduction of FIT to the clinics sharply demonstrates the value of bringing beneficial and newer screening modalities directly to the community. The clinics now have transitioned to the use of FIT. Second, the clinics in the current study are community partners with a long-standing history of collaboration with the TBCCN with regard to diverse community-based initiatives. As such, the clinics in the current study were highly invested in the development of the CARES targeted materials and opted to incorporate these materials into their clinical practice. However, it is important to note that these clinics may differ from other clinics in their willingness to adopt and/or their ability to incorporate such materials and/or screening with FIT into their clinical practice.
This trial had several strengths. First, participants were racially and ethnically diverse. Second, the current study addressed a lack of awareness regarding CRC screening, a common patient-reported barrier. 6 Third, the primary outcome was objectively based on return of completed FIT kits rather than self-report of CRC screening. Fourth, the 2 conditions received similar intervention dosing in that both groups were provided print materials, FIT kits, and demonstrations of FIT kit stool collection. This allowed testing of the contribution of targeting on screening uptake. Finally, the current study demonstrated high acceptance by patients of the high-sensitivity and high-specificity, 1-sample FIT tests; FIT offers a low-cost and potentially sustainable screening modality to community safety-net clinics. This contributes favorably to improving the Uniform Data Standards (UDS) and Healthcare Effectiveness Data and Information Set (HEDIS) quality assurance measures throughout their organizations, 60, 61 and was perceived as a favorable outcome of the study by community partners.
With regard to limitations, the first is that a combined intervention consisting of distribution of FIT kits, written and verbal kit instructions, collection demonstration, and education was used in both conditions. Therefore, we were unable to fully determine which components of the intervention were most effective given the high uptake rate. Second, this trial did not contain a usual-care intervention condition. Due to ethical concerns related to the proven merits of screening, every patient in the study had access to CRC education and a FIT kit. However, as discussed earlier, 2 credible measures were used to approximate baseline and usual-care benchmarking. Third, patients not screened in the current trial could have sought or received screening elsewhere; however, medical record review suggests this was unlikely. Fourth, there may be selection bias because the study enrolled and randomized only consented patients instead of randomizing all patients who were not up-to-date on screening. Fifth, this trial focused on boosting CRC screening in clinics with initial FIT testing. However, the effectiveness of a CRC screening strategy with FIT depends heavily on adherence to repeat annual FIT testing. Prior studies have shown repeat screening rates are often low despite high initial testing. [62] [63] [64] Sixth, there may be some bias due to the use of logistic regression and the reporting of ORs versus log-linear regression and risk ratios. The analytic approach was selected for 2 reasons: 1) due to the large number of potential covariates that were not binary; and 2) the common use of this approach in the literature, including our previous research, which would allow for comparisons. Finally, the current study included patients living in a single geographic region, thereby limiting generalizability.
The results of the current and other interventions indicate that a simple, scalable, FIT-based intervention will help to reduce disparities in CRC screening in FQHCs and CHCs. Future studies are needed to examine the relative efficacy of the CARES intervention on sustaining annual FIT screening and whether adding other components such as patient navigation or coaching improves return rates among patients who do not return their FIT kit. In addition, the use of computerized/electronic tracking systems and other multilevel system elements 29 should be explored to enhance and sustain annual repeat FIT screening to ultimately improve health equity. The clinics are committed to using the FIT and nontargeted materials for the general population, and reserve the targeted CARES materials plus FIT for those patients requiring more personalized in-depth education. Although clinics view this blended education approach as a cost-efficient strategy, additional research is needed to evaluate long-term sustainability and impact.
Conclusions
Although there were no significant differences in FIT uptake noted between the targeted and nontargeted material conditions, overall FIT uptake in this sample was high. Consistent with other studies, the strongest interventions to increase CRC screening include low-literacy educational materials that do not require a physician/clinician to implement 26 and include access to screening. 29, 54, 55 CRC screening with FIT holds high appeal for community clinics because they assiduously work to promote the health message "the best test is the one that gets done." 29 Boosting CRC screening with FIT or similar highly accepted modalities holds great promise for reducing health disparities. 
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